GE, Roche partner to build digital diagnostics platform for oncology, critical care

GE Healthcare and Roche partnered to develop a digital clinical decision support solution, focusing on products that accelerate and improve personalized cancer and critical care treatments, the companies said Monday.

Advertisement

As part of the agreement, the companies will work to build an analytics-enabled, digital platform that offers workflow solutions and apps supporting clinical decisions. The platform will allow integration and analysis of in-vivo and in-vitro data, patient records, medical best practice, real-time monitoring and the latest research outcomes.

“This is the first time that two major players in healthcare have combined advanced analytics with in-vivo and in-vitro diagnostics to this degree. We believe this alliance will help accelerate the delivery of data-driven precision health for customers, patients and the healthcare industry,” said Kieran Murphy, president and CEO of GE Healthcare.

More articles on health IT:

Medical device supplier DJO Global notifies Las Vegas hospital of lost patient data

Bitcoin for teeth Dentacoin’s value up 900% in 1 month

Philips, American Well team up in global telehealth venture

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.